NCT02238236View on ClinicalTrials.gov

Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

CompletedOBSERVATIONAL
Enrollment

3,793

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2008

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Alesion®

Dry Syrup

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02238236 - Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus | Biotech Hunter | Biotech Hunter